Advanced Cancer Clinical Trial
Official title:
Living With Hope: Developing a Psychosocial Supportive Program for Rural Older Women Caregivers of Spouses With Advanced Cancer
Family caregivers of terminally ill persons describe hope as inner strength that will help them continue caregiving. Our research team has developed and pilot tested a Living with Hope Program (LWHP) for caregivers of family members with advanced cancer, with the goal of fostering hope and improving quality of life (www.usask.ca/nursing /research/livingwithhope). The caregivers involved in our pilot test found the LWHP easy to use and we found some evidence to suggest that the program may have increased their hope and improved their quality of life. We would like to further develop and test the LWHP by finding out more about how and how long it might work. We believe it will improve the quality of life of active and bereaved older rural women of persons with advanced cancer and may decrease the number of prescriptions and doctor visits over one year. Since rural women caring for persons with advanced cancer seem to have the least hope, we want to focus on them first before including other caregivers in our research. Two hundred rural women caring for a person with advanced cancer will be asked to take part in this study. Their feelings of control, loss and grief, quality of life and hope will be measured over a year. The numbers of time they visit their physician and how many prescriptions they have over the year will also be collected. This study will contribute to the refinement of a Living with Hope Program that may improve quality of life and personal health of older rural women caring for their spouse with advanced cancer and those who subsequently become bereaved.
1. Background: The research team has developed and pilot tested a Living with Hope Program
(LWHP) for caregivers of family members with advanced cancer. The LWHP includes viewing
an award winning Living with Hope video followed by writing a daily journal for two
weeks. The pilot test findings suggested that the LWHP is an acceptable and feasible
intervention for use by family caregivers. Although the LWHP shows promise in
potentially increasing hope and quality of life, further testing and development is
needed. Questions remain as to: a) what are the mechanisms through which the LWHP
affects outcomes and b) how long it is effective?
2. Purpose: The overall purpose of this time series mixed method study is the further
development and testing of the LWHP by:
1. Determining the mechanisms of the LWHP by testing the LWHP conceptual model in
which self-efficacy and loss and grief are hypothesized intervening variables for
changes in hope, and subsequently quality of life among rural women caring for
persons with advanced cancer. In the LWHP model we hypothesize that administration
of the LWHP will improve self-efficacy and decrease feelings of loss and grief.
This will lead to a positive influence on the proximal outcome of hope and the
distal outcome of quality of life.
2. Exploring the longitudinal effects of the LWHP on hope, quality of life and health
services utilization among older rural women caring for spouses with advanced
cancer. We want to determine if the LWHP has benefits beyond what was found in the
pilot. The team will compare baseline scores of hope and quality of life to scores
after the LWHP over time and health services utilization (one year prospective
number of physician visits and prescriptions compared to the year before the
LWHP). This study is unique, as it will follow caregivers over a one-year period.
As approximately 50% of these caregivers will become bereaved one month after
study enrolment; rather than dropping these caregivers from the study, the team
felt that retaining these subjects would add to the understanding of hope, quality
of life and health care utilization among caregivers by continuing to follow them
through bereavement. Thus, patterns of hope, quality of life and health care
services utilization will be delineated over time for active and bereaved
caregivers.
3. Research Plan: Using a time-series embedded mixed method design, baseline measures were
collected from 122 rural women caring for a person who has advanced cancer. Data
collection began January 2009 in 4 sites: Saskatoon Cancer Agency, Alan Blair Cancer
Agency, Sunrise Health Region and Regina/Qu'Appelle Health Region. Data collection in
Alberta started July 2010 through Alberta Health Services Community Cancer Clinics, and
in September 2010 through a mail out through the Alberta Cancer Registry. In January
2011 subjects were enrolled through a mail out through the Saskatchewan Cancer
Registry. Subjects who consented to participate in the full study received the LWHP.
Subjects were then post tested on the variables at 1 and 2 weeks, 3, 6 and 12 months.
Journal entries were copied and transcribed.
4. Data Analysis: Path Analysis will be used to test the model post LWHP at 1 and 2 weeks.
Two-factor ANCOVA will determine patterns over time and Cortazzi's narrative analysis
will be used to analyze the subjects journals completed as part of the LWHP.
5. Significance: This study will contribute to the refinement of the Living with Hope
Program that may improve quality of life and personal health of older rural women
caring for their spouse with advanced cancer and those who subsequently become
bereaved. The findings will also increase our understanding of the factors influencing
hope, quality of life and health in a vulnerable, understudied population that is
increasing in numbers with the aging of Canada's population. Family care giving is what
sustains patients at the end of life, and with changing demographics and diminishing
resources there is a potential that every Canadian will be an informal caregiver at
some time. Effective psychosocial supportive interventions, such as the LWHP are
critical for their support and well-being.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181854 -
Randomized Controlled Trial of Integrated Early Palliative Care
|
N/A | |
Completed |
NCT01197170 -
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
|
Phase 1 | |
Recruiting |
NCT05045040 -
Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03994601 -
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Completed |
NCT01393990 -
A Study of LY2228820 in Participants With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02857270 -
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT04121676 -
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer
|
Phase 1 | |
Active, not recruiting |
NCT03177291 -
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
|
Phase 1 | |
Completed |
NCT03980041 -
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
|
Phase 2 | |
Active, not recruiting |
NCT03674567 -
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
|
Phase 1/Phase 2 | |
Recruiting |
NCT04823377 -
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
|
N/A | |
Completed |
NCT02778126 -
A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02529553 -
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
|
Phase 1 | |
Completed |
NCT02507544 -
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02245204 -
Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers
|
Phase 1 | |
Terminated |
NCT01929941 -
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT01583777 -
Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer
|
Phase 1 |